chr9-132166965-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 2P and 16B. PM1BP4_StrongBP6_Very_StrongBS2
The NM_032536.4(NTNG2):c.134G>A(p.Arg45His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00724 in 1,614,232 control chromosomes in the GnomAD database, including 72 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0056 ( 9 hom., cov: 33)
Exomes 𝑓: 0.0074 ( 63 hom. )
Consequence
NTNG2
NM_032536.4 missense
NM_032536.4 missense
Scores
5
13
Clinical Significance
Conservation
PhyloP100: 2.22
Genes affected
NTNG2 (HGNC:14288): (netrin G2) Predicted to be involved in several processes, including basement membrane assembly; cell morphogenesis involved in differentiation; and regulation of cell projection organization. Located in Flemming body; intercellular bridge; and plasma membrane. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
PM1
In a domain Laminin N-terminal (size 251) in uniprot entity NTNG2_HUMAN there are 8 pathogenic changes around while only 1 benign (89%) in NM_032536.4
BP4
Computational evidence support a benign effect (MetaRNN=0.0054740906).
BP6
Variant 9-132166965-G-A is Benign according to our data. Variant chr9-132166965-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 777189.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Homozygotes in GnomAd4 at 9 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
NTNG2 | NM_032536.4 | c.134G>A | p.Arg45His | missense_variant | 2/8 | ENST00000393229.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
NTNG2 | ENST00000393229.4 | c.134G>A | p.Arg45His | missense_variant | 2/8 | 1 | NM_032536.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00558 AC: 850AN: 152232Hom.: 9 Cov.: 33
GnomAD3 genomes
AF:
AC:
850
AN:
152232
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00599 AC: 1507AN: 251446Hom.: 13 AF XY: 0.00603 AC XY: 820AN XY: 135914
GnomAD3 exomes
AF:
AC:
1507
AN:
251446
Hom.:
AF XY:
AC XY:
820
AN XY:
135914
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00742 AC: 10845AN: 1461882Hom.: 63 Cov.: 31 AF XY: 0.00718 AC XY: 5223AN XY: 727242
GnomAD4 exome
AF:
AC:
10845
AN:
1461882
Hom.:
Cov.:
31
AF XY:
AC XY:
5223
AN XY:
727242
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00557 AC: 849AN: 152350Hom.: 9 Cov.: 33 AF XY: 0.00561 AC XY: 418AN XY: 74512
GnomAD4 genome
AF:
AC:
849
AN:
152350
Hom.:
Cov.:
33
AF XY:
AC XY:
418
AN XY:
74512
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
28
ALSPAC
AF:
AC:
31
ESP6500AA
AF:
AC:
10
ESP6500EA
AF:
AC:
55
ExAC
AF:
AC:
781
Asia WGS
AF:
AC:
1
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jul 01, 2024 | NTNG2: BP4, BS2 - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Benign
.;T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Benign
N;N
MutationTaster
Benign
N;N;N;N
PrimateAI
Benign
T
PROVEAN
Benign
N;N
REVEL
Benign
Sift
Benign
T;T
Sift4G
Benign
T;D
Polyphen
0.93
.;P
Vest4
MVP
MPC
1.9
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at